Kellokumpu-Lehtinen, P. (2007) “Cost-effectiveness of intensive adjuvant chemotherapy for high-risk breast cancer: Is tailored and dose-escalated chemotherapy with growth factor support (GFS) more costly and less effective than marrow-supported high-dose chemotherapy – results from a ra”, Acta Oncologica, 46(2), pp. 146–152. doi: 10.1080/02841860600965012.